Hong Kong stock exchange filings show that on August 27, Zhu Hongbing sold 1.8396 million shares of BAYZED HEALTH (02609) at an average price of HK$3.1612 per share, totaling approximately HK$5.8153 million.
Following the transaction, Zhu's latest shareholding stands at around 78.5634 million shares, representing a 5.96% stake in the company. The deal involves related parties including Cui Yifan, Shanghai Xukun Enterprise Management Co., Ltd., and Shanghai Xuxi Enterprise Management Partnership (Limited Partnership).